https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689389/
Introduction. Gastric cancer is a common cancer and 1 of the leading causes of cancer-related deaths worldwide. 1 Gastric cancer tends to migrate proximally, and the incidence of proximal gastric cancer has increased since 1976. 2,3 The standard surgical treatment to advanced upper-third gastric cancer (AUTGC) recommended by the Japanese Gastric Cancer Association is total gastrectomy with D2

https://www.sages.org/video/laparoscopic-total-gastrectomy-omentectomy-spleenectomy-for-gastric-adenocarcinoma/
Laparoscopic Total Gastrectomy, Omentectomy, Spleenectomy for Gastric Adenocarcinoma Presented by Gautam Sharma at the SS04: Video: Dentes to Dentate Session during the SAGES 2016 Annual Meeting.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508137/
1. Introduction. Gastric cancer (GC) is the fourth most common cancer worldwide. In 2020, a total of 1,089,103 (5.6% of all cancer) new gastric cancer cases, causing 768,793 deaths (7.7% of all cancer), were estimated [].Although its global incidence has been declining, GC is still one of the leading causes of cancer-related mortality, especially in Asia.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831884/
Total omentectomy was added in cT3-4 cases, with the decision made at the time of surgery. ... Yoshida M, Nishiguchi Y, Harada J. Feasibility of laparoscopic total gastrectomy with splenectomy for proximal advanced gastric cancer: A ... Hiki N, Etoh T, et al. Introducing laparoscopic total gastrectomy for gastric cancer in general practice: a

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787257
Key Points. Question What are the 3-year outcomes after laparoscopic total gastrectomy combined with spleen-preserving splenic hilar lymphadenectomy for patients with locally advanced proximal gastric cancer?. Findings In this nonrandomized clinical trial of 251 patients with clinically staged, locally advanced upper-third gastric cancer, the 3-year overall survival was 79.1%.

https://www.nature.com/articles/s41598-020-73367-8
Gastric cancer is the fifth most common cancer worldwide, with an estimated 952,000 new cases (7% of total cancer incidence) and 723,000 deaths (9% of total cancer mortality) in 2012 1.

https://link.springer.com/article/10.1007/s00423-023-02789-5
Purpose Gastric cancer (GC) is the fifth most common malignancy worldwide and portends a grim prognosis due to a lack of appreciable improvement in 5-year survival. We aimed to analyze the available literature and summarize the current standards of surgical care for curative and palliative intent treatment of GC. Methods We conducted a systematic search on the PubMed database for studies on

https://www.mskcc.org/cancer-care/types/stomach-gastric/treatment/surgery
Request an Appointment. Call 800-525-2225. Available Monday through Friday, 8 a.m. to 6 p.m. (Eastern time) Make an appointment. Surgery (gastrectomy) is a common treatment for stomach cancer, most often when the condition is in an early stage.

https://link.springer.com/chapter/10.1007/978-3-031-19671-3_49
Gastric adenocarcinoma. Objectives. 1. Discuss the indications and contraindications for a laparoscopic total or subtotal gastrectomy. 2. Discuss preoperative planning for patients with gastric adenocarcinoma. 3. Review the technical components of a laparoscopic gastrectomy and lymphadenectomy. 4.

https://ascopubs.org/doi/10.1200/JCO.2019.37.4_suppl.139
139 Background: In patients with locally advanced gastric cancer, total gastrectomy with splenectomy (TGS) is sometimes indicated when a tumor directly infiltrates the spleen or obvious splenic hilar lymph node metastasis exists. However, this procedure is technically demanding and can cause potentially fatal postoperative pancreas-related complications. TGS has increasingly been performed

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078159/
Introduction. Gastric cancer (GC) is the fifth most common malignancy worldwide, and the third leading cause of cancer-related death.1, 2 In the era of improved outcomes with a multidisciplinary approach, surgery continues to be the cornerstone of treatment.3 Minimally invasive gastrectomy (MIG) has been proven to be a safe alternative in Distal Gastrectomies (DG),4 - 8 showing decreased

https://jenci.springeropen.com/articles/10.1186/s43046-022-00114-7
In locally advanced distal gastric cancer, laparoscopic radical distal gastrectomy is safe and effective as shown by CLASS 01, KLASS 02 trials [15, 16]. But for total gastrectomy the ongoing JLSSG0901 trial will make clear the outcomes and benefits of Laparoscopic procedure in locally advanced gastric cancers (Table 1.).

https://pubmed.ncbi.nlm.nih.gov/27280511/
Objective: To clarify the role of splenectomy in total gastrectomy for proximal gastric cancer. Backgrounds: Splenectomy in total gastrectomy is associated with increased operative morbidity and mortality, but its survival benefit is unclear. Previous randomized controlled trials were underpowered and inconclusive. Methods: We conducted a multiinstitutional randomized controlled trial.

https://wjso.biomedcentral.com/articles/10.1186/1477-7819-12-64
Background Minimally invasive surgery has been slowly introduced into the field of advanced gastric cancer (AGC) surgery. However, the appropriate extent of omentectomy during laparoscopic gastrectomy for AGC is unknown. Methods From July 2004 to December 2011, 146 patients with serosa-negative advanced gastric cancer were divided into the total omentectomy group (TO group, n = 80) and the

https://pubmed.ncbi.nlm.nih.gov/25318360/
Background: Since its widespread acceptance for the treatment of early gastric cancer, laparoscopic gastrectomy has been gaining popularity as a treatment option for advanced gastric cancer. However, laparoscopic total gastrectomy (LTG) with splenectomy is seldom performed, because of its difficulty of removal of station 10 lymph nodes; splenectomy is technically essential for complete removal

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817857/
1. Introduction. Gastric cancer is the fifth most common cancer worldwide and the fourth most common cause of cancer-related death [].The incidence of upper stomach and esophagogastric junction (EGJ) cancer is increasing worldwide, particularly in the western world and with similar trends in eastern countries [2,3,4,5,6].Therefore, the use of total gastrectomy (TG) for the treatment of

https://www.youtube.com/watch?v=U-T7amTUNN4
Presented by Gautam Sharma at the SS04: Video: Dentes to Dentate Session during the SAGES 2016 Annual Meeting.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811676/
Despite the recent decrease in the incidence of gastric cancer globally, it is still the third leading cause of cancer-associated mortality (1,2).Recent years have witnessed a gradual increase in the incidence of proximal gastric cancer in Western and Asian countries ().Total or proximal gastrectomy combined with adequate lymph node dissection is the standard surgical procedure for proximal

https://link.springer.com/article/10.1007/s00464-024-10891-y
A 21-year-old lady underwent total robotic choledochal cyst (CDC) excision and hepaticojejunostomy (HJ) for Type IVa CDC 2 years back. ... Robotic Revision from Sleeve Gastrectomy to Roux-en-Y Gastric Bypass in Setting of Intestinal Malrotation ... laparoscopic splenectomy has been proven a safe alternative to open splenectomy in the trauma

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747491/
Postoperative surgical complications after laparoscopic total gastrectomy for gastric cancer (n=74) Reoperation Mortality; n n n; Esophagojejunal anastomosis fistula ... A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery. 2002; 131:401-407

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368152/
The incidence of metastatic omental LN of patients undergoing radical gastrectomy due to GC is extremely low. Total omentectomy may be avoided in tumors smaller than 5.25 cm and T1/T2 tumors. However, the presence of lymph node metastases in the greater omentum is associated with recurrence in the peritoneum, liver, ovary and death.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580580/
JCOG1401, a single-arm confirmatory trial, also showed the safety of laparoscopic total gastrectomy (LTG) and proximal gastrectomy (LPG) for patients with clinical stage I gastric cancer . Based on these results, LG is recommended as a standard treatment for clinical stage I gastric cancer in the Japanese Gastric Cancer Treatment Guidelines [ 3 ].

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649556/
They did not detect a statistical difference between the groups with omentum-sparing gastrectomy and gastric tumor and those who underwent omentectomy. In their study of 100 patients with gastric tumor, Jongerius et al [ 16 ] reported that 5% of the patients had omental metastases, and these were patients with T3 and T4 lymph node involvement.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405117/
The most common histological type of GC is gastric adenocarcinoma, which is classified into ... Total gastrectomy for lesions larger than 4 cm, proximal gastrectomy for patients with ... Zhang NY, Wu ZY, Feng JY, Ying LP, Zhang JJ. Laparoscopic gastrectomy versus open gastrectomy for elderly patients with gastric cancer: a systematic review and